MedTrace Logo

Investigating My Active and Healthy Aging

NCT03342976 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 201

Last updated 2023-11-30

No results posted yet for this study

Summary

This is a multicenter, multicultural, randomized control trial. Participants will be recruited from 10 centers located in Italy, Germany, Austria, Spain, United Kingdom, Belgium, Sweden, Japan, South Korea and Australia. The main objective of the study is to examine the efficacy of a sensor-based platform (my-AHA platform) to assess frailty risks and to deliver tailored interventions in order to prevent in elderly subjects conversion from a pre-frail status to a frailty status.

Conditions

Interventions

OTHER

My-AHA platform

ICT strategy for early detection of frailties

Sponsors & Collaborators

  • University of Turin, Italy

    lead OTHER

Principal Investigators

  • Georg Aumayr, PhD · Johanniter International

  • Helios De Rosario, PhD · IBV-Gesmed, Spain

  • Mathew Summers, PhD · Sunshine Coast University, Australia

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-03
Primary Completion
2020-10-30
Completion
2020-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03342976 on ClinicalTrials.gov